Amgen & Novartis
5 shared events · Importance 3 · Last updated Jul 29, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Amgen: Amgen is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Novartis: Novartis is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Business
Amgen: Amgen's Repatha is a competitor to Scribe's STX-1150 in the PCSK9 inhibitor space. The success of Scribe's therapy could impact Amgen's market share in cholesterol management.
Novartis: Novartis' Leqvio is another competitor in the PCSK9 inhibitor market. Scribe's progress may affect Novartis's competitive position.
Jul 06, 2026 · 25 articles
Business
Amgen: Amgen is mentioned as a previous employer of Dr. Zack, where she served as Global Development Lead for Enbrel.
Novartis: Novartis is mentioned as a previous employer where Dr. Zack worked in the Biotherapeutics Development Unit.
Jul 27, 2026 · 6 articles
Regulatory
Novartis: Novartis is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Amgen and Novartis interact across events, view sentiment trends, and discover connected entities.
Open Dashboard